Clinical Trial Update: DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating dexamethasone combined with rituximab, cyclosporine, and IVIG for newly diagnosed immune thromboc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• DEXAMETHASONE (Dexamethasone)
• Intravenous Immunoglobulin (IVIG)
• Rituximab (rituximab)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 3 | Status: UNKNOWN